wholesale sales of the company's flagship naturalizer brand were up 6.1 percent versus last year. brown shoe's lifestride brand of women's footwear had a wholesale sales gain of 2.7 percent. the company's dr. scholl's-licensed footwear business to mass merchants posted a strong increase over last year, while the children's business was even with the prior year.
outlook for the second quarter and full year
the company currently estimates fiscal 2005 diluted earnings per share in the range of $2.30 to $2.45, as compared to its previous guidance of $2.55 to $2.65 per diluted share and last year's diluted earnings per share of $2.30. the current estimated range (i) no longer reflects $0.20 per share in costs associated with the expensing of stock options, (ii) reflects an estimated expense of $0.55 per diluted share in incremental tax provisions related to the repatriation of foreign earnings, and (iii) reflects the anticipated accretion of $0.15 to $0.20 per share from the acquisition of bennett footwear.
excluding the incremental tax costs, the estimated 2005 diluted adjusted earnings per share are anticipated to be in the range of $2.85 to $3.00. this guidance is predicated on an assumed store-for-store sales increase of 1 percent to 2 percent for famous footwear over the full year.
fiscal 2005 net sales are currently estimated at $2.3 billion, versus fiscal 2004 net sales of $1.9 billion.
for the second quarter, brown shois guidance is predicated on an assumed store-for-store sales increase of 1 percent to 2 percent for famous footwear over the full year.
marketing@alchempro.com
